What is Elevance Health's ingenio rx — reportable segments operating revenues?

Elevance Health (ELV) reported ingenio rx — reportable segments operating revenues of $6.55B in Q3 2021.

Discontinued — last reported Q3 '21

Business Segments · Reportable segments operating revenues

Ingenio Rx — Reportable segments operating revenues

Elevance Health Ingenio Rx — Reportable segments operating revenues increased by 5.3% to $6.55B in Q3 2021 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityStable

First reportedQ1 2019

Last reportedQ3 2021

How to read this metric

An increase indicates growth in pharmacy service volume or pricing, while a decrease may signal loss of contracts or market share.

Detailed definition

This metric represents the total operating revenue generated by the pharmacy benefit management segment from external cu...

Peer comparison

Comparable to 'segment revenue' reported by any major pharmacy benefit manager or diversified health insurer.

Metric ID: elv_segment_ingeniorx_segment_reportable_segments_operating_revenues

Historical Data

2 periods

	Q2 '21	Q3 '21
Value	$6.22B	$6.55B
QoQ Change	—	+5.3%

Range$6.22B – $6.55B

Similar Metrics at Other Companies

CVS HealthCVS View metric

PfizerPFE View metric

SRE

Sempra EnergySRE View metric

Analog DevicesADI View metric

Xcel EnergyXEL View metric

HumanaHUM View metric

Frequently Asked Questions

What is Elevance Health's ingenio rx — reportable segments operating revenues?: Elevance Health (ELV) reported ingenio rx — reportable segments operating revenues of $6.55B in Q3 2021.
What does ingenio rx — reportable segments operating revenues mean?: The total sales or revenue generated by the pharmacy benefit management business segment.